Assessment of unclassified variants in the BRCA1 and BRCA2 genes identified by clinical genetic testing: D1739V is a deleterious BRCA1 missense mutation

Translated title of the contribution: Assessment of unclassified variants in the BRCA1 and BRCA2 genes identified by clinical genetic testing: D1739V is a deleterious BRCA1 missense mutation
  • R.B. van der Luijt
  • , W. Gaasbeek
  • , A.Y. Bronkhorst
  • , C.W.F. van Helvert
  • , H. van der Spaa
  • , M. Gijzen
  • , B.G. Smith
  • , R.P.M Jansen
  • , P.H.A van Zon
  • , M.G.E.M. Ausems
  • , B.P.M. van Nesselrooij
  • , J.G. Post
  • , T.G.W. Letteboer
  • , E. van Riel
  • , A.E. Schoemaker
  • , J. van Echtelt
  • , Y. Cuperus
  • , R.J. Sinke
  • , J.K. Ploos van Amstel

Research output: Contribution to conferencePosterOther research output

Translated title of the contributionAssessment of unclassified variants in the BRCA1 and BRCA2 genes identified by clinical genetic testing: D1739V is a deleterious BRCA1 missense mutation
Original languageUndefined/Unknown
Publication statusPublished - 5 Jun 2008
EventFamilial Cancer Conference - Madrid
Duration: 5 Jun 20086 Jun 2008

Conference

ConferenceFamilial Cancer Conference
CityMadrid
Period5/06/086/06/08

Keywords

  • Econometric and Statistical Methods: General
  • Genetics
  • Geneeskunde(GENK)
  • Algemeen onderzoek

Cite this